Commonwealth Equity Services’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,041
| Closed | -$560K | – | 4026 |
|
|
2023
Q4 | $560K | Buy |
7,041
+300
| +4% | +$23.9K | ﹤0.01% | 2605 |
|
|
2023
Q3 | $471K | Buy |
6,741
+1,558
| +30% | +$109K | ﹤0.01% | 2650 |
|
|
2023
Q2 | $372K | Buy |
+5,183
| New | +$372K | ﹤0.01% | 2856 |
|
|
2023
Q1 | – | Sell |
-9,624
| Closed | -$742K | – | 3779 |
|
|
2022
Q4 | $742K | Sell |
9,624
-576
| -6% | -$44.4K | ﹤0.01% | 2153 |
|
|
2022
Q3 | $455K | Sell |
10,200
-1,473
| -13% | -$65.7K | ﹤0.01% | 2486 |
|
|
2022
Q2 | $447K | Sell |
11,673
-1,318
| -10% | -$50.5K | ﹤0.01% | 2489 |
|
|
2022
Q1 | $537K | Sell |
12,991
-3,993
| -24% | -$165K | ﹤0.01% | 2462 |
|
|
2021
Q4 | $641K | Buy |
16,984
+2,079
| +14% | +$78.5K | ﹤0.01% | 2323 |
|
|
2021
Q3 | $491K | Buy |
+14,905
| New | +$491K | ﹤0.01% | 2483 |
|